New Horizons guide will help you acclimate to your new deserted island, and walk you through the ins and outs of how to best ...

Marines often boast that their beloved Corps was “born in a bar,” specifically, that it was born at Tun Tavern in Philadelphia, back when the very first would-be Marines decided to enlist on Nov. 10, ...

The scientists at Miramax have apparently been working in the lab late at night coming up with an idea for an eerie sight. And what they’ve come up with is adapting someone else’s. The studio is ...

EXCLUSIVE: The 1962 song “Monster Mash,” which has become an annual Halloween +hit, is becoming an animated movie at Miramax. Miramax CEO Jonathan Glickman, who has been behind such haunted hits as ...

“Monster Mash” by Bobby “Boris” Pickett and the Crypt-Kickers has just been crowned the biggest Halloween song of all time by Billboard! The iconic hit was first released in August 1962, and spent two ...

After a decade operating at The Rim shopping center, Mash’D — a restaurant and bar specializing in “Rebellious American” fare — will shut down Wednesday, Oct. 29, according to a social media post. In ...

For years, MASH was where drug development dreams went to die. One trial after another failed. Companies bowed out. The field earned a reputation as one of biopharma’s most intractable challenges: a ...

Metabolic-associated steatohepatitis (MASH) happens when excess fat in the liver causes inflammation and scarring, or fibrosis. The condition is serious, and when left untreated it can lead to ...

Hall of Fame quarterback Dan Marino recently revealed that he was diagnosed with metabolic dysfunction-associated steatohepatitis, or MASH. The Miami Dolphins legend said the discovery came years ago ...

Marine veteran Monty Dahm has long wanted to build a replica of Tun Tavern, the legendary birthplace of the U.S. Marine Corps, near its original site in Philadelphia. Earlier this month, he reached an ...

Roche dived into the metabolic dysfunction-associated steatohepatitis (MASH) space by agreeing to hand over up to $3.5 billion for 89bio and its phase-3-stage candidate for the fatty liver disease. At ...